Ensign Peak Advisors, Inc
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in CRNX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,739,399
-$10,090,525 QoQ
Shares Held
75,424
-72.6% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,687 across 116 Biotechnology names. CRNX ranks #63 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in CRNX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,739,399 | 75,424 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,829,924 | 275,616 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,287,083 | 295,008 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,075,620 | 315,564 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,266,693 | 514,809 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,702,539 | 502,690 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $31,520,370 | 616,837 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,600,807 | 616,227 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $29,092,742 | 621,507 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,501,672 | 435,685 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,440,531 | 384,685 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,870,247 | 270,269 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,340,520 | 270,269 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,945,922 | 270,269 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,813,243 | 92,324 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,578,237 | 84,624 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,338,093 | 60,961 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $971,650 | 34,201 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $444,597 | 21,121 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $16,228 | 1,104 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||